Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy.
Saved in:
| Title: | Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy. |
|---|---|
| Authors: | Long, Junyu1 (AUTHOR), Yang, Xu1 (AUTHOR), Bian, Jin1 (AUTHOR), Wang, Dongxu1 (AUTHOR), Wang, Anqiang2 (AUTHOR), Lin, Yu3 (AUTHOR), Zheng, Mingjun4 (AUTHOR), Zhang, Haohai5 (AUTHOR), Sang, Xinting1 (AUTHOR) sangxt@pumch.cn, Zhao, Haitao1 (AUTHOR) ZhaoHT@pumch.cn |
| Source: | Clinical & Translational Medicine. Nov2021, Vol. 11 Issue 11, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 153877284 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Long%2C+Junyu%22">Long, Junyu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Xu%22">Yang, Xu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bian%2C+Jin%22">Bian, Jin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Dongxu%22">Wang, Dongxu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Anqiang%22">Wang, Anqiang</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Yu%22">Lin, Yu</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Mingjun%22">Zheng, Mingjun</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Haohai%22">Zhang, Haohai</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sang%2C+Xinting%22">Sang, Xinting</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> sangxt@pumch.cn</i><br /><searchLink fieldCode="AR" term="%22Zhao%2C+Haitao%22">Zhao, Haitao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> ZhaoHT@pumch.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Translational+Medicine%22">Clinical & Translational Medicine</searchLink>. Nov2021, Vol. 11 Issue 11, p1-5. 5p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=153877284 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ctm2.598 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 1 Titles: – TitleFull: Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Long, Junyu – PersonEntity: Name: NameFull: Yang, Xu – PersonEntity: Name: NameFull: Bian, Jin – PersonEntity: Name: NameFull: Wang, Dongxu – PersonEntity: Name: NameFull: Wang, Anqiang – PersonEntity: Name: NameFull: Lin, Yu – PersonEntity: Name: NameFull: Zheng, Mingjun – PersonEntity: Name: NameFull: Zhang, Haohai – PersonEntity: Name: NameFull: Sang, Xinting – PersonEntity: Name: NameFull: Zhao, Haitao IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 20011326 Numbering: – Type: volume Value: 11 – Type: issue Value: 11 Titles: – TitleFull: Clinical & Translational Medicine Type: main |
| ResultId | 1 |